Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Concord Biotech share rises 6% after USFDA clears Tofacitinib Tablets ANDA
Concord Biotech shares jumped 5.8 per cent on BSE after USFDA cleared Tofacitinib Tablets ANDA

Concord Biotech shares gain 5% after bagging USFDA approval for $500 million drug
According to Concord Biotech, this development aligns directly with its long-term growth strategy, aimed at reinforcing its commercial footprint across both US and international markets.
Volumes jump at Concord Biotech Ltd counter
Concord Biotech Ltd witnessed volume of 1.68 lakh shares by 10:46 IST on BSE, a 9.35 times surge over two-week average daily volume of 17948 shares
Stock Alert: APSEZ, Infosys, Dhanuka Agritech, Concord Biotech, Mufin Green Finance, Canara Bank
Adani Ports & Special Economic Zone (APSEZ) handled cargo volumes of 48.3 million metric tonnes (MMT) in May, marking a 16% year-on-year increase, driven by strong growth across key ports and cargo segments. However, the company's logistics business witnessed a decline, with rail volumes falling 19% year-on-year to 48,170 TEUs during the month.

Stocks to Watch for June 3: Canara Bank, Adani Ports, John Cockerill, Concord Biotech and more
Adani Ports cargo up 15%, rail volumes down 19 percent, Canara Bank to raise ₹8500 crore via bonds, Concord Biotech gets US FDA nod, Dhanuka Agritech starts buyback. Here are few stocks to track ahead of Wednesday trading session.

Concord Biotech gets FDA nod for immunosuppressant mycophenolate mofetil
Mycophenolate mofetil is an antimetabolite immunosuppressant indicated for the prophylaxis of organ rejection in adult and paediatric recipients aged three months and older of allogeneic kidney, heart or liver transplants, in combination with other immunosuppressants. Shares of Concord Biotech Ltd ended at ₹1,166.80, up by ₹106.20, or 10.01%, on the BSE today, June 2.

Top Gainers & Losers on June 2: Newgen Software Tech, Concord Biotech, TCS, HFCL, NMDC among top gainers
On June 2, Indian stocks rebounded with benchmarks up over 0.5%, driven by technology shares. The Nifty 50 and Sensex closed at 23,506 and 74,692, respectively. However, India fell to seventh in global market capitalisation due to overseas selling and weak earnings growth.
Newgen Software Technologies Ltd leads gainers in 'A' group
Concord Biotech Ltd, ACME Solar Holdings Ltd, Sky Gold & Diamonds Ltd and Tata Consultancy Services Ltd are among the other gainers in the BSE's 'A' group today, 02 June 2026.

Concord Biotech Q4 profit slides 37%, margins shrink; declares ₹7.55 dividend
The board recommended a dividend of ₹7.55 per share dividend. Shares of Concord Biotech closed 4.46% lower at ₹1,050.60 on the NSE on Friday, May 29.

Trade Spotlight: How should you trade Concord Biotech, Jindal Steel, Axis Bank, Aegis Logistics, Raymond, and others on June 11?
The market is likely to witness further consolidation, with Monday's low serving as an important support level. Below are some short-term trading ideas to consider.

Stocks to Watch Today: InterGlobe Aviation, Concord Biotech, NMDC, Lumax Auto Tech, Olectra Greentech, Cyient. Lupin, PB Fintech in focus on 01 June
Stocks to Watch, 1 Jun: InterGlobe Aviation, Gujarat Gas, Concord Biotech, Indian Renewable Energy Development Agency, NMDC, Glenmark Pharma, Olectra Greentech, Lumax Auto Technologies, Inox Wind, PNC Infratech, and Cyient will be in focus on June 1.

Stocks to Watch Today: Infosys, Bliss GVS Pharma, Vedanta, John Cockerill, Concord Biotech, Rajnandini Fashion, Anand Rathi Wealth in focus on 03 June
Stocks to Watch, 03 June: Stocks like Infosys, Vedanta, Hindustan Zinc, Bliss GVS Pharma, Dhanuka Agritech, Advait Energy Transitions, John Cockerill India, Concord Biotech, InterGlobe Aviation, Rajnandini Fashion India, and Anand Rathi Wealth will be in focus on June 3.